FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
U.S. Officials Say Afghan Suspect in D.C. National Guard Shooting Radicalized After Arrival 
New Orleans Immigration Crackdown Sparks Fear as Federal Arrests Intensify 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Trump Claims He Will Void Biden Documents Signed with Autopen 
National Guard Member Killed in White House-Area Shooting Sparks Terror Probe and Immigration Review 
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure 
BOJ Faces Pressure for Clarity, but Neutral Rate Estimates Likely to Stay Vague 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
UN Chief Says Gaza Operation “Fundamentally Wrong” as Concerns Over War Crimes Grow 
California Launches Portal for Reporting Alleged Misconduct by Federal Immigration Agents 
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures 
Australia and Japan Strengthen Defence Cooperation Amid Rising Regional Tensions 
Germany’s Economic Recovery Slows as Trade Tensions and Rising Costs Weigh on Growth 
Flights Briefly Grounded at Philadelphia International Airport After Bomb Threat Resolved 
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut 
U.S. President Donald Trump has unveiled a new round of steep tariffs on a wide range of imported goods, sparking concerns about inflation and international trade relations. Beginning October 1, the U.S. will impose 100% tariffs on branded and patented pharmaceutical imports, 25% tariffs on heavy-duty trucks, 50% tariffs on kitchen cabinets and bathroom vanities, and 30% tariffs on upholstered furniture.
Trump argued the measures are needed to protect American industries from what he called “flooding” of foreign products. He emphasized that the new pharmaceutical tariffs will not apply to companies already building manufacturing facilities in the U.S. The administration framed the truck tariffs as essential for safeguarding domestic manufacturers like Peterbilt, Kenworth, and Freightliner, while countering growing competition from Mexico, Canada, Japan, and Europe.
Industry groups, however, are pushing back. The Pharmaceutical Research and Manufacturers of America warned that the policy could disrupt supply chains, noting that over half of U.S. medicine ingredients are already produced domestically, with the remainder coming from allies in Europe and beyond. Similarly, the U.S. Chamber of Commerce criticized the truck tariffs, pointing out that Mexico—America’s largest source of medium- and heavy-duty trucks—has deeply integrated supply chains with U.S. companies. Many of these trucks already contain 50% U.S.-made components.
Mexico, home to 14 truck and bus manufacturers, strongly opposed the move, stressing its role as the leading exporter of tractor trucks globally, with 95% of exports heading to the U.S. The Japanese Automobile Manufacturers Association also voiced opposition, highlighting that Japanese companies have already shifted much of their truck production to U.S. facilities.
Critics warn the tariffs may drive up transportation costs, undermining Trump’s pledge to fight inflation. The policies could also affect automakers like Stellantis, which builds Ram trucks in Mexico, and Volvo Group, which is investing $700 million in a new truck plant in Monterrey. With tariffs set to take effect next month, global trade tensions and inflation concerns are expected to intensify.
